Altium Capital Management »

Aprea Therapeutics shares owned by Altium Capital Management

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $558k 137k 4.07

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Intra Cellular Therapies (ITCI)
Sarepta Therapeutics (SRPT)
Insmed Com Par $.01 (INSM)
Alimera Sciences Com New
Skye Bioscience Com New (SKYE)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Avadel Pharmaceuticals Com Shs (AVDL)
Catalyst Pharmaceutical Partners (CPRX)
Contineum Therapeutics Cl A (CTNM)
Rezolute Com New (RZLT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for Altium Capital Management

Top funds holding Aprea Therapeutics

AIGH Capital Management
Sio Capital Management
Sphera Funds Management
Nantahala Capital Management
Altium Capital Management
DAFNA Capital Management
Exome Asset Management
Stonepine Capital Management
Vanguard Group
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
HighTower Advisors
Susquehanna International
BlackRock

View all funds holding Aprea Therapeutics